Zobrazeno 1 - 5
of 5
pro vyhledávání: '"I. A. Zaigraev"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 117-125 (2023)
Aim. To compare different scores in assessment of risk of left atrial or its appendage thrombosis (LAAT) in patients with non-valvular atrial fibrillation (AF) or atrial flutter (AFL) undergoing transesophageal echocardiography before catheter ablati
Externí odkaz:
https://doaj.org/article/c8dc4ab139b94eadad343ab6fba39146
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 12 (2023)
Aim. To determine the incidence of left atrial (LA) and/or LA appendage (LAA) thrombosis in patients with non-valvular atrial fibrillation (AF) (NAF) or atrial flutter (AFL) on transesophageal echocardiography (TEE) before elective catheter ablation
Externí odkaz:
https://doaj.org/article/4adc9b09b1d9448fa73b3ed704e0012a
Autor:
I. A. Zaigraev, I. S. Yavelov
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 56-70 (2020)
The review presents data on the feasibility of using laboratory findings to predict the presence of left atrium (LA) and/or left atrial appendage (LAA) thrombus in non-valvular atrial fibrillation (NvAF). It describes the relationship between the pre
Externí odkaz:
https://doaj.org/article/270010bcbac34cbb867b75e1fa434b3d
Autor:
E. F. Dadashova, E. M. Alekseeva, G. E. Gendlin, A. V Melehov, Igor G. Nikitin, I. A Zaigraev
Publikováno v:
Medical Journal of the Russian Federation. 23:116-126
The article presents results of analysis of the register of out-patients and in-patients with atrium fibrillation (n=1624) observed in 2009-2015. The retrospective data analysis and prospective observation of certain percentage of patients were appli
Autor:
G V, Rodoman, I R, Sumedi, S K, Zyryanov, M A, Ivzhits, O M, Romashov, M I, Aleksandrov, O Yu, Markina, M A, Lukin, I A, Zaigraev, M R, Smirnova
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 61(11-12)
In patients under artificial lung ventilation (ALV) there is often observed development of severe ventilator-associated pneumonia (VAP) due to polyresistant hospital pathogens. It should be noted that in the patient described here with the initial di